<!DOCTYPE html>
<html lang="en">
<head>
	
<?php $id='56-2007'; include '../../seo.php';?>

	<?php include '../../side-nav.php';?>
	<div class="page-content">
		<!--section-->
		<div class="section mt-0">
			<div class="breadcrumbs-wrap">
				<div class="container">
					<div class="breadcrumbs">
						<a href="https://sprintdiagnostics.in/">Home</a>
						<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
						<span>RT-PCR for Inv (16) Quantitative Test</span>
					</div>
				</div>
			</div>
		</div>
		<!--//section-->
		<!--section-->
		<div class="section page-content-first">
			<div class="container mt-6">
				<div class="row">
					<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
 					<h1 class="test-h1">RT-PCR for Inv (16) Quantitative Test</h1>
					<div class="post-text">
								<p>The RT-PCR for Inv (16) Quantitative Test is a diagnostic tool used to detect the presence and quantify
								the amount of the Inv (16) gene mutation in your blood or bone marrow. This specific gene mutation, a type of inversion, is commonly associated with a subtype of Acute Myeloid Leukemia (AML), known as AML-M4Eo. <br><br>
								Inversion in chromosome 16 or Inv (16) results in a fusion of two genes - the core-binding factor beta
								(CBFB) and the smooth muscle myosin heavy chain (MYH11). This fusion gene is not usually found in
								healthy individuals and its presence often suggests AML-M4Eo. The RT-PCR (Reverse Transcription
								Polymerase Chain Reaction) technique is utilized to amplify and quantitatively measure this fusion gene
								in the patient's sample.</p>
								
								<div class="table-wrap">
									<table class="table table-striped">
							  <thead>
							    <tr>
							      <th scope="col">Test Name</th>
							      <td scope="col">RT-PCR for Inv (16) Quantitative Test</td>
							      
							    </tr>
							  </thead>
							  <tbody>
							    <tr>
							      <th scope="row">Sample Type</th>
							      <td>Blood or Bone Marrow</td>
							      
							    </tr>
							    <tr>
							      <th scope="row">Preparations Required</th>
							      <td>No special preparation is required before this test.</td>
							      
							    </tr>
							    <tr>
							      <th scope="row">Report Time</th>
							      <td>7 Days</td>
							      
							    </tr>
								<tr>
							      <th scope="row">Price</th>
							      <td>â‚¹ 8000</td>
							      
							    </tr>
							  </tbody>
							</table>
							
						</div>
					<div class="post-text">
								<h2 class="test-h2 mt-3">What is the importance of the RT-PCR for Inv (16) Quantitative Test?</h2>
								<p>The test is vital for diagnosing AML-M4Eo, a specific subtype of AML characterized by the Inv (16) gene
mutation. Additionally, it aids in tracking disease progression and assessing the response to treatment.</p>
								
							
								<h2 class="test-h2 mt-3">Is fasting required for this test?</h2>
								<p>No, fasting is not necessary for this test.</p>
								
								<!--section achieved-->
								<?php include "../../include/iconsbox.php" ?>
								<!--//section achieved-->

								
								<h2 class="test-h2 mt-3">What type of sample is used for this test?</h2>
								<p>The test requires a sample of your blood or bone marrow.</p>
								
								
								
								<h2 class="test-h2 mt-3">When should I consider taking this test?</h2>
								<p>Your healthcare provider may suggest this test if you exhibit symptoms indicative of AML, or if you have
been previously diagnosed with AML and the efficacy of your treatment needs to be evaluated.</p>
								
								
								<h2 class="test-h2 mt-3">What information does this test provide?</h2>
								<p>This test detects and quantifies the Inv (16) fusion gene in your blood or bone marrow sample. The
presence and quantity of this gene can indicate the severity of AML-M4Eo and the effectiveness of the
treatment.</p>
								 	
								
								
								<h2 class="test-h2 mt-3">How often should I undergo this test?</h2>
								<p>The frequency of this test depends on your healthcare provider&#39;s advice, which will be based on your
diagnosis, treatment plan, and how well you respond to the treatment.</p>
								
								
								
								<h2 class="test-h2 mt-3">What are the normal values for this test?</h2>
								<p>Normally, the Inv (16) fusion gene is not present in the body. However, in individuals diagnosed with
AML-M4Eo, the aim of the treatment is to minimize the levels of this fusion gene.</p>

								<h2 class="test-h2 mt-3">What precautions should I take before this test?</h2>
								<p>No special precautions are needed before this test. However, it's important to inform your healthcare
provider about any medications you're taking as they could potentially interfere with the test results.</p>

								<h2 class="test-h2 mt-3">Can any factors affect the levels of the Inv (16) fusion gene?</h2>
								<p>Certain medications and the presence of other genetic abnormalities may affect the results of this test.</p>

								<h2 class="test-h2 mt-3">Who should I consult if my test results are abnormal?</h2>
								<p>An oncologist or a hematologist would be the appropriate specialists to consult in the case of abnormal
test results.</p>

								<h2 class="test-h2 mt-3">Which conditions might cause an abnormal result in this test?</h2>
								<p>The primary condition associated with the presence and an elevated level of the Inv (16) fusion gene is
AML-M4Eo. The levels of this fusion gene can decrease with effective treatment.</p>

								<h2 class="test-h2 mt-3">What should I expect during the sample collection process?	</h2>
								<p>For this test, a healthcare professional will draw a blood sample from a vein in your arm or collect a
bone marrow sample through a procedure known as bone marrow aspiration or biopsy.</p>

								<h2 class="test-h2 mt-3">Are there any risks associated with this test?</h2>
								<p>The test carries minimal risk. You may experience slight pain and bruising at the site of the blood draw
or bone marrow aspiration. In very rare cases, there could be a risk of infection.</p>

								<h2 class="test-h2 mt-3">Is this test conclusive for diagnosing AML-M4Eo?</h2>
								<p>The presence of the Inv (16) fusion gene strongly indicates AML-M4Eo. However, your healthcare
provider will typically use this test in conjunction with other diagnostic tests and clinical findings to
confirm a diagnosis.</p>

								<h2 class="test-h2 mt-3">Can the results of this test predict my prognosis if I have AML-M4Eo?</h2>
								<p>Yes, the results of this test can be used as a prognostic factor. Lower levels of the Inv (16) fusion genepost-treatment often indicate a better prognosis. Regular monitoring of this gene's levels can help your healthcare provider adjust your treatment plan as necessary.</p>

								
								<p>The RT-PCR for Inv (16) Quantitative Test plays a critical role in the diagnosis and management of AML-
M4Eo. While the test provides valuable information, it's essential to remember that open communication with your healthcare provider is crucial to understanding your overall health and treatment plan.</p>
 
							</div>		
						</div>			
							
							 
						
				</div>

		    <!--form section-->
				<?php include "../../include/bookslot.php" ?>
       <!--form section-->

			</div>
		</div>
		<!--//section-->
	</div>
	<?php include '../../footer.php';?>
</body>
</html>